DC_C66 is a cell-permeable, selective inhibitor of CARM1 (IC50 = 1.8 μM) with good selectivity over PRMT1 (IC50 = 21 μM), PRMT6 (IC50 = 47 μM), and PRMT5; it exhibits anti-proliferative activity in CARM1-associated cancer cell lines (e.g., HeLa, K562, MCF7) in a time- and dose-dependent manner.